top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
How to Formulate Drug Policies and Provide Evidence-Based Regulation
Authors: Steve Rolles, David Nutt & Anne Schlag Published: April 7, 2021 How do we end the war on drugs? With mounting evidence...
Dr Anne Schlag, Professor David Nutt and more
Apr 7, 20213 min read
MDMA for Alcohol Use Disorder
In this webinar, Dr Ben Sessa explains how MDMA therapy could treat alcohol use disorder (alcoholism), based on results from his recent...
Drug Science
Apr 5, 20212 min read
Can a ‘double standard’ in paediatric medicine provide a framework to restructure repressive medical
By Rayyan Zafar an Honorary Research Assistant for Drug Science Can a ‘double standard’ in paediatric medicine provide a framework to...
Rayyan Zafar
Apr 1, 20216 min read
Charlie Hughes’ family drop their court case against NICE
We are greatly encouraged by the news that NICE updated their guidelines around medical cannabis for children with severe epilepsy. The...
Drug Science
Mar 31, 20213 min read
Women in Psychedelic Science - Part 3
The Contradictions of Ketamine: results from a new clinical trial treating alcohol use disorder – Prof Celia Morgan Celia Morgan is a...
Drug Science
Mar 29, 20212 min read
What would a regulated stimulant market look like?
Prohibition has failed to reduce drug-related deaths and unregulated stimulant drugs such as cocaine and MDMA pose a significant risk to...
Drug Science
Mar 25, 20211 min read
Nonclinical abuse liability testing of new CNS-active drugs: Role of sex as a critical factor for drug scheduling
Authors: David V Gauvin, Zachary J Zimmermann, Mary Jeanne Kallman Published: March 17, 2021 The trends in addiction medicine suggest...
David V Gauvin, Zachary J Zimmermann and more
Mar 18, 20212 min read
Investing in Psychedelic Companies
As clinical trials reveal more evidence for the therapeutic potential of psychedelic drugs such as psilocybin, DMT, and even entheogens...
Drug Science
Mar 18, 20211 min read
Project Twenty21 - March Update
In this update, we reveal the latest data and patient feedback from Project Twenty21, and answer some common questions from patients. We...
Drug Science
Mar 12, 20213 min read
Psilocybin Treatment for Depression - Clinical Insights
Psilocybin for depression is one of the most promising applications of psychedelic therapy. In particular, psilocybin therapy is being...
Drug Science
Mar 11, 20211 min read
Statement Regarding Project Twenty21 and its Official Industry Partners
Statement from Drug Science regarding Project Twenty 21 and its official industry partners. For immediate release Drug Science would...
Drug Science
Mar 9, 20212 min read
Psilocybin Treatment for Depression - Patient Perspective
Clinical trials are currently investigating psilocybin therapy, as a treatment for depression at research centres around the world. This...
Drug Science
Mar 4, 20212 min read
Drug Testing and Synthetic Cannabis in Prisons
Written by Professor David Nutt Late on Saturday night, the 27th of February, I was asked to speak on the Stephen Nolan show on BBC Radio...
Professor David Nutt
Mar 3, 20214 min read
Psychedelic Microdosing - Just a Placebo Effect?
Authors: Balázs Szigeti, Laura Kartner, Allan Blemings, Fernando Rosas, Amanda Feilding, David J. Nutt, Robin L. Carhart-Harris, David...
Balázs Szigeti, Professor David Nutt and more
Mar 2, 20212 min read
Coming Out
By Dr Anna Ross, an Honorary Research Assistant for Drug Science A reflection on the article “Coming Out”: Stigma, reflexivity and the...
Dr Anna Ross
Mar 1, 20215 min read
Multi Criteria Decision Analysis for Evaluating Government Policy Responses to Heroin Use
Authors: Steve Rolles, Anne Katrin Schlag, Fiona Measham, Lawrence Phillips, David Nutt, Daniel Bergsvik, Ole Rogeberg Published:...
Dr Anne Schlag, Professor David Nutt and more
Feb 25, 20212 min read
David Nutt on Alcohol as a Drug
David Nutt – Deep Dive into Alcohol Alcohol is among the most harmful of all recreational drugs, and yet it is the most widely used in...
Drug Science
Feb 23, 20211 min read
In My Professional Opinion - Vaping and Tobacco Harm Reduction
Clive Bates – Vaping and Tobacco Harm Reduction Nicotine without smoke? This discussion takes a brief tour through the science and policy...
Drug Science
Feb 18, 20211 min read
Medical cannabis dependence: A critical review of issues and evidence
Authors: Anne K Schlag, Chandni Hindocha, Rayyan Zafar, David J Nutt, H Valerie Curran Published: February 17, 2021 This Drug Science...
Dr Anne Schlag, Professor David Nutt and more
Feb 17, 20212 min read
Drug Science submission to the WHO enquiry on vaping
Fifteen years ago, the World Health Organization developed the Framework Convention on Tobacco Control (FCTC), which aims to provide...
Professor David Nutt
Feb 12, 20215 min read
Childhood Epilepsy Case Study: Gino Londra
A Closer Look at the Families Struggling to Cope with the Huge Financial and Personal Burden of Accessing Medical Cannabis to Treat...
Danielle Johnson
Feb 9, 20217 min read
Get Your Copy of Nutt Uncut
David Nutt regularly hit the headlines as the UK’s forthright Drugs Czar (Chair of the Advisory Council on the Misuse of Drugs), not...
Drug Science
Feb 7, 20211 min read
Letter of recommendation to the ACMD
Download our letter to the Advisory Council on the Misuse of Drugs Dear Owen Bowden-Jones I am writing on behalf of Drug Science in...
Professor David Nutt
Feb 5, 20213 min read
2020 - The Year Of The Mushroom
By Dr Hannah Thurgur an Honorary Research Assistant for Drug Science As we welcome in the new year, Drug Science reflects on the year of...
Dr Hannah Thurgur
Feb 1, 20218 min read
bottom of page